Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a prospective cohort study (STAR.Ro)

OBJECTIVES: To assess the effectiveness and safety of insulin glargine and lixisenatide (iGlarLixi) fixed-ratio combination on a cohort of Romanian adults with type 2 diabetes (T2D). DESIGN: Open-label, 24-week, prospective cohort study. SETTING: 65 secondary care diabetes centres in Romania. PARTIC...

Descripción completa

Detalles Bibliográficos
Autores principales: Bala, Cornelia, Cerghizan, Anca, Mihai, Bogdan-Mircea, Moise, Mihaela, Guja, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150149/
https://www.ncbi.nlm.nih.gov/pubmed/35623748
http://dx.doi.org/10.1136/bmjopen-2022-060852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150149/
https://www.ncbi.nlm.nih.gov/pubmed/35623748
http://dx.doi.org/10.1136/bmjopen-2022-060852

Ejemplares similares